Position in VRTX
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$98,090,995
-$831,250 QoQ
Shares Held
219,669
+0.7% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80.78836795360293.ToString("F0")%
Shared 0.ToString("F0")%
None 19.211632046397078.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Welch & Forbes LLC holds $98,675,155 across 6 Biotechnology names. VRTX ranks #1 (99.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
219,669 | $98,090,995 | |
| 2 | SRRK |
Scholar Rock Holding Corp
|
5,000 | $245,800 | |
| 3 | DNA |
Ginkgo Bioworks Holdings, Inc.
|
30,000 | $183,900 | |
| 4 | CMPX |
Compass Therapeutics, Inc.
|
19,000 | $100,510 | |
| 5 | MIST |
Milestone Pharmaceuticals Inc.
|
25,000 | $29,750 | |
| 6 | DRMA |
Dermata Therapeutics, Inc.
|
20,000 | $24,200 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $98,090,995 | 219,669 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $98,922,245 | 218,198 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $86,296,307 | 220,346 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $96,717,028 | 217,244 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $100,667,539 | 207,639 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $79,646,408 | 197,781 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $91,443,564 | 196,619 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $91,352,121 | 194,897 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $80,651,267 | 192,941 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $76,652,786 | 188,387 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $64,356,241 | 185,070 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $65,034,375 | 184,804 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $58,671,705 | 186,218 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $54,340,021 | 188,171 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $54,855,669 | 189,458 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $54,169,337 | 192,233 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $51,034,771 | 195,558 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $41,708,628 | 189,930 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $36,647,491 | 202,037 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $41,610,181 | 206,369 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $45,058,135 | 209,680 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $45,227,913 | 191,368 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $50,255,665 | 184,682 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $54,142,234 | 186,498 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $43,394,227 | 182,367 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||